- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Pegylated recombinant human interleukin-10
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Pegylated recombinant human interleukin-10
| EU orphan designation number: | EU/3/16/1804
|
| Active ingredient: | Pegylated recombinant human interleukin-10 |
| Indication: | Treatment of pancreatic cancer |
| Sponsor: | Larode Ltd
Rhode Farm, Priory Lane, Selborne, Hampshire GU34 3BU, United Kingdom |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 15/12/2016 | Orphan designation | EMA/OD/193/16 | (2016)8704 of 12/12/2016 |
CONTACT
EU links
Directorate General Health & Consumers